Biochemistry of alpha-2 Adrenergic Receptors
John W. Regan
Abstract
John W. Regan
Abstract
Physiologic and pharmacologic studies provide the present basis for the classification of alpha-adrenergic receptors (Langer, 1974; Berthelsen and Pettinger, 1977; Wikberg, 1978; Starke, 1981). This classification calls for the existence of discrete alpha-1 and alpha-2 adrenergic receptors with the extant possibility of further subdivision among the alpha-2 adrenergic receptors (Cheung et al., 1982; McGrath and Reid, 1985; Bylund, 1985). Until recently, demonstrating the actual physical existence of the unique macromole-cules representing these alpha-adrenergic receptor subtypes has proved elusive. The difficulty in studying their biochemistry is primarily because most membrane-bound hormone receptors, including alpha-adrenergic receptors, are present only at very low concentrations in the cells of target tissues (i.e., frequently less than 0.001% of the total cellular protein). Therefore, a sensitive and reliable means of quantifying receptor activity was required before the biochemical characterization and purification of alpha-adrenergic receptors could progress. The means for the direct measurement of alpha-adrenergic receptor activity was acquired in 1976 with the development of [ 3 H]dihydroergocryptine ([ 3 H]DHE, Williams and Lefkowitz, 1976). These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Physiologic and pharmacologic studies provide the present basis for the classification of alpha-adrenergic receptors (Langer, 1974; Berthelsen and Pettinger, 1977; Wikberg, 1978; Starke, 1981). This classification calls for the existence of discrete alpha-1 and alpha-2 adrenergic receptors with the extant possibility of further subdivision among the alpha-2 adrenergic receptors (Cheung et al., 1982; McGrath and Reid, 1985; Bylund, 1985). Until recently, demonstrating the actual physical existence of the unique macromole-cules representing these alpha-adrenergic receptor subtypes has proved elusive. The difficulty in studying their biochemistry is primarily because most membrane-bound hormone receptors, including alpha-adrenergic receptors, are present only at very low concentrations in the cells of target tissues (i.e., frequently less than 0.001% of the total cellular protein). Therefore, a sensitive and reliable means of quantifying receptor activity was required before the biochemical characterization and purification of alpha-adrenergic receptors could progress. The means for the direct measurement of alpha-adrenergic receptor activity was acquired in 1976 with the development of [ 3 H]dihydroergocryptine ([ 3 H]DHE, Williams and Lefkowitz, 1976). These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Key concepts: Receptor, Alpha-1A adrenergic receptor, Adrenergic receptor, Alpha (finance), Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor, Alpha-2 adrenergic receptor, Adrenergic